Zopiclone 7.5 mg is one of the most commonly prescribed treatments for short-term insomnia in the UK. It belongs to a group of medicines known as Z-drugs, which act on the brain’s GABA-A receptors to produce a calming, sleep-inducing effect.
Clinical studies show that zopiclone 7.5 mg is effective at reducing the time it takes to fall asleep, increasing total sleep duration, and decreasing night-time awakenings. Its relatively rapid onset makes it suitable for patients who struggle with sleep initiation as well as sleep maintenance.
In UK practice, 7.5 mg is considered the standard adult dose, while a lower dose (3.75 mg) is recommended for elderly patients or those more sensitive to sedative effects. Evidence reviewed by the National Institute for Health and Care Excellence indicates that zopiclone has similar effectiveness to other Z-drugs, such as zolpidem and zaleplon, with no clear superiority between them.
Despite its effectiveness, zopiclone is recommended only for short-term use (typically 2–4 weeks). This restriction is due to risks of tolerance, dependence, and withdrawal symptoms if used for longer periods. Common side effects include a bitter or metallic taste, drowsiness, dizziness, and reduced alertness the next day.
UK safety guidance also highlights potential risks such as impaired driving ability and memory disturbances, particularly if the medication is taken late at night or combined with alcohol or other sedatives.
Current UK guidelines encourage prioritizing non-drug treatments, such as cognitive behavioural therapy for insomnia (CBT-i), before prescribing medications like zopiclone.
đź‘Ť Conclusion
Zopiclone 7.5 mg is an effective and widely used short-term treatment for insomnia in the UK. While it improves sleep quality and duration, its use is carefully limited due to safety concerns, and it is best used under medical supervision as part of a broader sleep management plan.
If you want, I can simplify this into exam notes, or compare it with zolpidem 10 mg or eszopiclone 2 mg.